GEISTWERT Rechtsanwälte Lawyers Avvocati

UPC_CFI_1439/2025

GlaxoSmithKline Biologicals SA v. Moderna Netherlands B.V. et. al

Datum
2026-06-12
Kammer
The Hague (NL) Local Division
Verfahrensart
Counterclaim for revocation
Sprache
EN

Metadaten

Fall-IDUPC_CFI_1439-2025-145de3e3ae9c
Aktenzeichen
RegisterzeichenUPC_CFI_1439/2025
Entscheidungsreferenz
Schlagwörter
Leitsätze

Dokumente und Volltext

Textextraktion: pypdf | Seiten: 7

1 The Hague - Local Division UPC_CFI_616/2025 UPC_CFI_1439/2025 R.105.5 Order of the Court of First Instance of the Unified Patent Court delivered on 12/06/2026 CLAIMANT/S 1) GlaxoSmithKline Biologicals SA (Claimant) - Rue de l'Institut 89 - 1330 - Rixensart - BE Represented by Tjibbe Douma, Carlos van Staveren, Nicole Jadeja and Emilia Zalewska of Bird & Bird LLP DEFENDANT/S 1) Moderna Netherlands B.V. (Defendant) - Claude Debussylaan 7 - 1082 MC - Amsterdam - NL 2) Moderna Biotech Spain, S.L. (Defendant) - C/Julián Camarillo 31 - 28037 - Madrid - ES 3) Moderna Biotech UK Limited (Defendant) - 54 Portland Place - W1B 1DY - London - GB 4) Moderna Biotech Distributor UK Ltd (Defendant) - MYO, 123 Victoria Street - SW1E 6DE - London - GB 2 5) Moderna Switzerland GmbH (Defendant) - Peter Meri ...